Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMPEDIMED LIMITED Capital/Financing Update 2014

Nov 10, 2014

65135_rns_2014-11-10_ac787155-c971-424e-8787-0f05a7e3233d.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [104 x 96] intentionally omitted <==

MARKET RELEASE

11 November 2014

ImpediMed Limited

TRADING HALT

The securities of ImpediMed Limited (the “Company”) will be placed in Trading Halt Session State at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in Trading Halt Session State until the commencement of normal trading on Thursday, 13 November 2014 or when the announcement is released to the market.

Security Code: IPD

Lisa Banh Adviser, Listings Compliance

Page 1 of 1

==> picture [96 x 86] intentionally omitted <==

11 November 2014

By email : [email protected]

Ms Lisa Banh ASX Compliance Pty Ltd 20 Bridge Street SYDNEY NSW 2000

Dear Lisa,

ImpediMed Limited – Request for trading halt under Listing Rule 17.1

ImpediMed Limited ( ImpediMed ) requests a trading halt in its shares from the commencement of trading today, Tuesday 11 November 2014 until the commencement of trading on Thursday 13 November 2014.

In accordance with Listing Rule 17.1, I advise that:

  • (a) ImpediMed is seeking the trading halt pending the making of an announcement to the market in relation to a proposed capital raising. The price and number of shares which will be issued is yet to be determined;

  • (b) ImpediMed is seeking the trading halt to assist in managing its disclosure obligations in relation to the proposed capital raising and maintaining an orderly market in the trading of the Company’s shares and to ensure that trading does not take place in an uninformed market;

  • (c) ImpediMed requests that the trading halt last until the earlier of the commencement of trading on Thursday 13 November 2014 or when ImpediMed makes an announcement to the market concerning the proposed capital raising;

  • (d) ImpediMed is not aware of any reason why the trading halt should not be granted.

If you have any further questions, please do not hesitate to contact me.

Yours faithfully

==> picture [100 x 33] intentionally omitted <==

Steve Denaro

Company Secretary

ImpediMed Limited ABN 65 089 705 144

Unit 1, 50 Parker Court, Pinkenba, QLD 4008 Australia • Tel +61 (7) 3860-3700 Fax +61 (7) 3260-1225 www.impedimed.com